Patent · US Active

Triazolopyridine compounds

US8349824B2 · kind B2 · utility

4Cited by

0References

26Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Alexander Flohr · Basel, CH
Luca Gobbi · Muttenz, CH
Katrin Groebke Zbinden · Liestal, CH
Matthias Koerner · Antdorf, DE
Jens-Uwe Peters · Weil am Rhein, DE

Key dates

Filing date	Dec 1, 2011
Grant date	Jan 8, 2013
Priority date	—
Expiry date	Dec 1, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is concerned with triazolopyridine compounds of formula (I)wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.